Výsledky vyhledávání - "P O, Bendahl"

Noninvasive Staging of Lymph Node Status (NILS) in Breast Cancer using Machine Learning: External Validation and Further Model Development

Autor: M. Hjärtström, L. Dihge, P. O. Bendahl, I. Skarping, J. Ellbrant, M. Ohlsson, L. Rydén

BackgroundMost patients diagnosed with breast cancer present with node-negative disease. Sentinel lymph node biopsy (SLNB) is routinely used to stage the axilla, leaving patients with healthy axillary lymph nodes without therapeutic effects but at ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0fe785e40e5a3b49894d940e4c05a6e9
https://doi.org/10.1101/2023.02.11.23285691

Zobrazit plný text záznamu

Akademický článek

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

Autor: E Gezelius, A Flou Kristensen, P O Bendahl, Y Hisada, S Risom Kristensen, L Ek, B Bergman, M Wallberg, U Falkmer, N Mackman, S Pedersen, M Belting

Publikováno v: PLoS ONE, Vol 13, Iss 11, p e0207387 (2018)

Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the

Externí odkaz: https://doaj.org/article/fc411eef701d46fe82a4b9ad222dfd3f

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Abstract P4-14-10: Withdrawn

Autor: Bo Nordenskjöld, Olle Stål, Maria Ekholm, Mårten Fernö, Lisa Rydén, P-O Bendahl

Publikováno v: Cancer Research. 79:P4-14

This abstract was withdrawn by the authors. Citation Format: Ekholm M, Bendahl P-O, Fernö M, Nordenskjöld B, Stål O, Rydén L. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Ph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fe0c0dfeb8d574cb862c2ff51ad98a2
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-10

Zobrazit plný text záznamu

Abstract P3-13-03: Risk factors for reoperation following breast-conserving surgery integrated into pre- and postoperative models with high accuracy

Autor: Lisa Rydén, J Ellrant, E Plassgård, P-O Bendahl

Publikováno v: Cancer Research. 79:P3-13

Purpose: Breast-conserving surgery (BCS) is today applied in 60-70% of patients with invasive and in situ cancer and tumor size of 3 cm or less. However, a significant fraction of patients (10-40%) who undergo BCS require a reoperation due to incompl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0827dce4b7290752847218b6c054095b
https://doi.org/10.1158/1538-7445.sabcs18-p3-13-03

Zobrazit plný text záznamu

St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

Autor: Looket Dihge, Ulrik Narbe, Lisa Rydén, Mårten Fernö, Christian Ingvar, P-O Bendahl

Publikováno v: The British journal of surgery. 108(12)

The St Gallen 2019 guidelines for primary therapy of early breast cancer recommend omission of completion axillary lymph node dissection (cALND), regardless of histological type, in patients with one or two sentinel lymph node (SLN) metastases. Concu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b745b7454b81564c84fb1bbfdcf77c
https://pubmed.ncbi.nlm.nih.gov/34636842

Zobrazit plný text záznamu

Abstract P3-08-13: Serum thymidine kinase activity is an independent prognostic factor for progression-free and overall survival in women with metastatic breast cancer

Autor: A-M Larsson, Kristina Aaltonen, Sara Jansson, Lisa Rydén, P-O Bendahl, Sharyn D. Baker, Michael Bergqvist

Publikováno v: Cancer Research. 78:P3-08

Introduction: Although prognosis and treatment of metastatic breast cancer (MBC) have improved over the last years, there is still an unmet clinical need for more precise prognostic and treatment monitoring tools. Liquid-based markers are preferred s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::899a8f941920864c3f83354fba4d1243
https://doi.org/10.1158/1538-7445.sabcs17-p3-08-13

Zobrazit plný text záznamu

Abstract P1-07-05: AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma

Autor: Kristina Lövgren, Mårten Fernö, Martin Sjöström, Lisa Rydén, P-O Bendahl, Sara Alkner, Ulrik Narbe, Carina Forsare, Christian Ingvar, Flm Leeb-Lundberg

Publikováno v: Cancer Research. 78:P1-07

Background: Estrogen receptor (ER) positive HER2-negative breast cancer comprises 75–80% of all breast cancer. This fraction is even higher (>90%) in invasive lobular carcinoma (ILC). According to the St Gallen surrogate definitions of the intrinsi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b52e87d79f9c9cb5ca7cd2c69cbc46d3
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-05

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání